Dexamethasone enhances ATP-induced inflammatory responses in endothelial cells

Journal of Pharmacology and Experimental Therapeutics

Volumn 335, Issue 3, 2010, Pages 693-702

  Ding, Yi ^a   Gao, Zhan Guo ^b   Jacobson, Kenneth A ^b   Suffredini, Anthony F ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ADENOSINE TRIPHOSPHATE; DEXAMETHASONE; INTERLEUKIN 6; MESSENGER RNA; MIFEPRISTONE; PURINERGIC P2Y2 RECEPTOR; SMALL INTERFERING RNA;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE SILENCING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; POSITIVE FEEDBACK; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; CALCIUM SIGNALING; CELL ADHESION MOLECULES; CELL LINE; CHEMOKINE CCL2; CYTOKINES; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; KINETICS; LIPOPOLYSACCHARIDES; MIFEPRISTONE; NUCLEAR PROTEINS; NUCLEOTIDES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PURINERGIC P2 RECEPTOR ANTAGONISTS; RECEPTORS, GLUCOCORTICOID; RECEPTORS, PURINERGIC P2Y2; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SURAMIN; TYPE C PHOSPHOLIPASES; UP-REGULATION;

EID: 78649545971     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.110.171975     Document Type: Article

References (44)

1. Abbracchio MP, Burnstock G, Boeynaems JM, Barnard EA, Boyer JL, Kennedy C, Knight GE, Fumagalli M, Gachet C, Jacobson KA, et al. (2006) International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol Rev 58:281-341. (Pubitemid 44394905)
2. Agca C, Seye C, Kashuba Benson CM, Rikka S, Chan AW, Weisman GA, and Agca Y (2009) Development of a novel transgenic rat overexpressing the P2Y(2) nucleotide receptor using a lentiviral vector. J Vasc Res 46:447-458.
3. Barber AE, Coyle SM, Marano MA, Fischer E, Calvano SE, Fong Y, Moldawer LL, and Lowry SF (1993) Glucocorticoid therapy alters hormonal and cytokine responses to endotoxin in man. J Immunol 150:1999-2006. (Pubitemid 23129678)
4. Bender A, Zapolanski T, Watkins S, Khosraviani A, Seiffert K, Ding W, Wagner JA, and Granstein RD (2008) Tetracycline suppresses ATP gamma S-induced CXCL8 and CXCL1 production by the human dermal microvascular endothelial cell-1 (HMEC-1) cell line and primary human dermal microvascular endothelial cells. Exp Dermatol 17:752-760.
5. Bolego C, Ceruti S, Brambilla R, Puglisi L, Cattabeni F, Burnstock G, and Abbracchio MP (1997) Characterization of the signalling pathways involved in ATP and basic fibroblast growth factor-induced astrogliosis. Br J Pharmacol 121:1692-1699. (Pubitemid 27343398)
6. Bours MJ, Swennen EL, Di Virgilio F, Cronstein BN, and Dagnelie PC (2006) Adenosine 5′-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. Pharmacol Ther 112:358-404. (Pubitemid 44486409)
7. Brealey D, Brand M, Hargreaves I, Heales S, Land J, Smolenski R, Davies NA, Cooper CE, and Singer M (2002) Association between mitochondrial dysfunction and severity and outcome of septic shock. Lancet 360:219-223. (Pubitemid 34804650)
8. Chaudry IH, Sayeed MM, and Baue AE (1976) Alterations in high-energy phosphates in hemorrhagic shock as related to tissue and organ function. Surgery 79:666-668.
9. 3 receptors. Science 314:1792-1795.
10. Chesnokova V and Melmed S (2002) Minireview: Neuro-immuno-endocrine modulation of the hypothalamic-pituitary-adrenal (HPA) axis by gp130 signaling molecules. Endocrinology 143:1571-1574. (Pubitemid 34415869)
11. 2 receptor transcription is increased by NF-kappa B and stimulates cyclooxygenase-2 expression and PGE2 released by intestinal epithelial cells. J Immunol 183:4521-4529.
12. Di Virgilio F, Borea PA, and Illes P (2001a) P2 receptors meet the immune system. Trends Pharmacol Sci 22:5-7.
13. Di Virgilio F, Chiozzi P, Ferrari D, Falzoni S, Sanz JM, Morelli A, Torboli M, Bolognesi G, and Baricordi OR (2001b) Nucleotide receptors: an emerging family of regulatory molecules in blood cells. Blood 97:587-600. (Pubitemid 32113390)
14. Erlinge D and Burnstock G (2008) P2 receptors in cardiovascular regulation and disease. Purinergic Signal 4:1-20.
15. Galon J, Franchimont D, Hiroi N, Frey G, Boettner A, Ehrhart-Bornstein M, O'Shea JJ, Chrousos GP, and Bornstein SR (2002) Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J 16:61-71. (Pubitemid 34027951)
16. Geary C, Akinbi H, Korfhagen T, Fabre JE, Boucher R, and Rice W (2005) Increased susceptibility of purinergic receptor-deficient mice to lung infection with Pseudomonas aeruginosa. Am J Physiol Lung Cell Mol Physiol 289:L890-L895. (Pubitemid 41504422)
17. Goding JW, Grobben B, and Slegers H (2003) Physiological and pathophysiological functions of the ecto-nucleotide pyrophosphatase/ phosphodiesterase family. Biochim Biophys Acta 1638:1-19. (Pubitemid 36577366)
18. Gorman MW, Feigl EO, and Buffington CW (2007) Human plasma ATP concentration. Clin Chem 53:318-325.
19. Han JZ, Lin W, and Chen YZ (2005) Inhibition of ATP-induced calcium influx in HT4 cells by glucocorticoids: involvement of protein kinase A. Acta Pharmacol Sin 26:199-204. (Pubitemid 40203966)
20. Heyninck K and Beyaert R (2005) A20 inhibits NF-kappaB activation by dual ubiquitin-editing functions. Trends Biochem Sci 30:1-4. (Pubitemid 40093732)
21. Humphreys BD and Dubyak GR (1996) Induction of the P2z/P2X7 nucleotide receptor and associated phospholipase D activity by lipopolysaccharide and IFN-gamma in the human THP-1 monocytic cell line. J Immunol 157:5627-5637.
22. 2 receptors control the recruitment of neutrophils to the lungs in a mouse model of sepsis. Shock 30:173-177.
23. Jabs CM, Ferrell WJ, and Robb HJ (1979) Plasma changes in endotoxin and anaphylactic shock (ATP, ADP and Creatine phosphorus). Ann Clin Lab Sci 9:121-132.
24. 2 nucleotide receptor mRNA expression is an immediate early gene response in activated thymocytes. Proc Natl Acad Sci USA 94:831-836.
25. Krishnaswamy G, Kelley J, Yerra L, Smith JK, and Chi DS (1999) Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res 19:91-104. (Pubitemid 29109625)
26. Liu XH, Zeng JW, Zhao YD, Chen PH, Xiao Z, and Ruan HZ (2008) Rapid inhibition of ATP-induced currents by corticosterone in rat dorsal root ganglion neurons. Pharmacology 82:164-170.
27. Martin KA, Kertesy SB, and Dubyak GR (1997) Down-regulation of P2U-purinergic nucleotide receptor messenger RNA expression during in vitro differentiation of human myeloid leukocytes by phorbol esters or inflammatory activators. Mol Pharmacol 51:97-108.
28. Minneci PC, Deans KJ, Eichacker PQ, and Natanson C (2009) The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysis. Clin Microbiol Infect 15:308-318.
29. Nicholas RA, Watt WC, Lazarowski ER, Li Q, and Harden K (1996) Uridine nucleotide selectivity of three phospholipase C-activating P2 receptors: identification of a UDP-selective, a UTP-selective, and an ATP- and UTP-specific receptor. Mol Pharmacol 50:224-229. (Pubitemid 26265124)
30. Pellegatti P, Raffaghello L, Bianchi G, Piccardi F, Pistoia V, and Di Virgilio F (2008) Increased level of extracellular ATP at tumor sites: in vivo imaging with plasma membrane luciferase. PLoS One 3:e2599.
31. Pober JS, Min W, and Bradley JR (2009) Mechanisms of endothelial dysfunction, injury, and death. Annu Rev Pathol 4:71-95.
32. Rao DA and Pober JS (2008) Endothelial injury, alarmins, and allograft rejection. Crit Rev Immunol 28:229-248.
33. Rebbe NF and Hickman S (1991) Modulation of nucleotide pyrophosphatase in plasmacytoma cells. Biochem Biophys Res Commun 175:637-644.
34. Rich PB, Douillet CD, Mahler SA, Husain SA, and Boucher RC (2003) Adenosine triphosphate is released during injurious mechanical ventilation and contributes to lung edema. J Trauma 55:290-297.
35. Schneider M, Ulsenheimer A, Christ M, and Wehling M (1997) Nongenomic effects of aldosterone on intracellular calcium in porcine endothelial cells. Am J Physiol 272:E616-E620. (Pubitemid 27194699)
36. Schwiebert LM, Rice WC, Kudlow BA, Taylor AL, and Schwiebert EM (2002) Extracellular ATP signaling and P2X nucleotide receptors in monolayers of primary human vascular endothelial cells. Am J Physiol Cell Physiol 282:C289-C301. (Pubitemid 34663188)
37. Seekamp A, van Griensven M, Hildebrandt F, Wahlers T, and Tscherne H (1999) Adenosine-triphosphate in trauma-related and elective hypothermia. J Trauma 47:673-683.
38. Seiffert K, Ding W, Wagner JA, and Granstein RD (2006) ATPgammaS enhances the production of inflammatory mediators by a human dermal endothelial cell line via purinergic receptor signaling. J Invest Dermatol 126:1017-1027.
39. Swerlick RA and Lawley TJ (1993) Role of microvascular endothelial cells in inflammation. J Invest Dermatol 100:111S-115S.
40. Trautmann A (2009) Extracellular ATP in the immune system: more than just a "danger signal." Sci Signal 2:pe6.
41. Urbach V, Walsh DE, Mainprice B, Bousquet J, and Harvey BJ (2002) Rapid non-genomic inhibition of ATP-induced Cl- secretion by dexamethasone in human bronchial epithelium. J Physiol 545:869-878. (Pubitemid 36024426)
42. van der Poll T, Coyle SM, Barbosa K, Braxton CC, and Lowry SF (1996) Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. J Clin Invest 97:713-719. (Pubitemid 26057090)
43. Walker BR (2007) Glucocorticoids and cardiovascular disease. Eur J Endocrinol 157:545-559.
44. Yu HB and Finlay BB (2008) The caspase-1 inflammasome: a pilot of innate immune responses. Cell Host Microbe 4:198-208.